These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 27449667
1. HLA-G 3'-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development. Cilião Alves DC, Haddad R, Rocha-Júnior MC, de Deus Wagatsuma VM, Martelli-Palomino G, Marques AA, Takayanagui OM, Covas DT, Kashima S, Donadi EA. J Gen Virol; 2016 Oct; 97(10):2742-2752. PubMed ID: 27449667 [Abstract] [Full Text] [Related]
2. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina. Benencio P, Fraile Gonzalez SA, Ducasa N, Page K, Berini CA, Biglione MM. Retrovirology; 2020 Sep 03; 17(1):29. PubMed ID: 32883310 [Abstract] [Full Text] [Related]
3. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1. Talledo M, López G, Huyghe JR, Verdonck K, González E, Clark D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L. J Med Virol; 2012 Feb 03; 84(2):319-26. PubMed ID: 22170554 [Abstract] [Full Text] [Related]
4. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP. Grassi MF, Olavarria VN, Kruschewsky Rde A, Mascarenhas RE, Dourado I, Correia LC, de Castro-Costa CM, Galvão-Castro B. J Med Virol; 2011 Jul 03; 83(7):1269-74. PubMed ID: 21567429 [Abstract] [Full Text] [Related]
5. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil. Schor D, Porto LC, Roma EH, Quintana MSB, Fabricio-Silva GM, Bonecini-Almeida MG, Araújo AQ, Andrada-Serpa MJ. BMC Infect Dis; 2018 Nov 22; 18(1):593. PubMed ID: 30466392 [Abstract] [Full Text] [Related]
6. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Kodama D, Tanaka M, Matsuzaki T, Izumo K, Nakano N, Matsuura E, Saito M, Nagai M, Horiuchi M, Utsunomiya A, Takashima H, Kubota R, Izumo S. PLoS Negl Trop Dis; 2020 Jul 22; 14(7):e0008361. PubMed ID: 32667912 [Abstract] [Full Text] [Related]
7. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis. Tarokhian H, Taghadosi M, Rafatpanah H, Rajaei T, Azarpazhooh MR, Valizadeh N, Rezaee SAR. Virus Res; 2017 Jan 15; 228():1-6. PubMed ID: 27845163 [Abstract] [Full Text] [Related]
8. HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load. Tanaka M, Takenouchi N, Arishima S, Matsuzaki T, Nozuma S, Matsuura E, Takashima H, Kubota R. Int J Mol Sci; 2024 Jun 22; 25(13):. PubMed ID: 38999966 [Abstract] [Full Text] [Related]
9. Polymorphisms in HTLV-1 Tax-responsive elements in HTLV-1-associated myelopathy/tropical spastic paraparesis patients are associated with reduced proviral load but not with disease progression. Gomes YCP, Silva MTT, Leite ACCB, Lima MASD, Araújo AQC, Silva Filho IL, Vicente ACP, Espíndola OM. J Gen Virol; 2021 Sep 22; 102(9):. PubMed ID: 34494950 [Abstract] [Full Text] [Related]
10. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients. Casseb J, de Oliveira AC, Vergara MP, Montanheiro P, Bonasser F, Meilman Ferreira C, Smid J, Duarte AJ. J Med Virol; 2008 Mar 22; 80(3):392-8. PubMed ID: 18205234 [Abstract] [Full Text] [Related]
11. Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects. Assone T, Malta FM, Bakkour S, Montalvo L, Paiva AM, Smid J, de Oliveira ACP, de Toledo Gonçalves F, do Carmo Luiz O, Fonseca LAM, Norris PJ, Casseb J. Virus Res; 2018 Jan 15; 244():71-74. PubMed ID: 29129607 [Abstract] [Full Text] [Related]
12. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR. Proc Natl Acad Sci U S A; 1999 Mar 30; 96(7):3848-53. PubMed ID: 10097126 [Abstract] [Full Text] [Related]
13. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development. Espíndola OM, Oliveira LC, Ferreira PM, Leite AC, Lima MA, Andrada-Serpa MJ. Intervirology; 2015 Mar 30; 58(2):106-14. PubMed ID: 25833232 [Abstract] [Full Text] [Related]
14. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE, Bunce M, Eiraku N, Izumo S, Usuku K, Osame M, Bangham CR. J Infect Dis; 2002 Oct 01; 186(7):932-9. PubMed ID: 12232833 [Abstract] [Full Text] [Related]
15. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, Izumo S, Usuku K, Welsh KI, Osame M, Bangham CR. J Immunol; 2000 Dec 15; 165(12):7278-84. PubMed ID: 11120862 [Abstract] [Full Text] [Related]
16. Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene. Costa GC, Azevedo R, Gadelha SR, Kashima SH, Muricy G, Olavarria VN, Covas DT, Takayanagui OM, Galvão-Castro B, Alcantara LC. J Med Virol; 2009 Mar 15; 81(3):552-7. PubMed ID: 19152396 [Abstract] [Full Text] [Related]
17. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease. Furtado Mdos S, Andrade RG, Romanelli LC, Ribeiro MA, Ribas JG, Torres EB, Barbosa-Stancioli EF, Proietti AB, Martins ML. J Med Virol; 2012 Apr 15; 84(4):664-71. PubMed ID: 22337307 [Abstract] [Full Text] [Related]
18. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S. AIDS Res Hum Retroviruses; 2000 Nov 01; 16(16):1705-9. PubMed ID: 11080814 [Abstract] [Full Text] [Related]
19. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects. Bidkhori HR, Hedayati-Moghaddam MR, Mosavat A, Valizadeh N, Tadayon M, Ahmadi Ghezeldasht S, Rafatpanah H, Rezaee SA. J Neurovirol; 2020 Jun 01; 26(3):338-346. PubMed ID: 32270468 [Abstract] [Full Text] [Related]
20. Evolution of HTLV-1 proviral load in patients from Salvador, Brazil. Olavarria VN, Gomes Ado N, Kruschewsky Rde A, Galvão-Castro B, Grassi MF. Braz J Infect Dis; 2012 Jun 01; 16(4):357-60. PubMed ID: 22846124 [Abstract] [Full Text] [Related] Page: [Next] [New Search]